Clinical Trials in Portland

Showing 881-900 of 10,048 trials

BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an Endoscopy

NCT06335966

Recent advancements in swallowable esophageal cell-collection devices (SECD) offer a safe, minimally invasive, accurate, and low-cost alternative to esophageal screening without the need for an upper endoscopy. The BEST-RPP study aims to evaluate the acceptability and feasibility of using this novel approach to screen for Barrett's Esophagus (BE) and Esophageal Carcinoma (EAC) in rural primary care clinic settings in Oregon.

Esophageal Cancer

OHSU Knight Cancer Institute110 participantsStarted Sep 2024

Portland, Oregon, United States

Active Not RecruitingPhase 3< 1 mile

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

NCT00379340

This phase III trial is studying how well combination chemotherapy with or without radiation therapy works in treating young patients with newly diagnosed stage III or stage IV Wilms' tumor. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving more than one drug (combination chemotherapy) with or without radiation therapy may kill more tumor cells.

Stage III Kidney Wilms TumorStage IV Kidney Wilms Tumor

Children's Oncology Group395 participantsStarted Apr 2007

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Mobile, Alabama, United States +224 more locations

BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an Endoscopy

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

Find Trials by Condition in Portland

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

Improving Medical Decision Making for Older Patients With End Stage Renal Disease

Mucopolysaccharidosis VII Disease Monitoring Program

Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)

Hip Arthroscopy Versus Total Hip Arthroplasty RCT

Taurine Supplementation in Long COVID

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE)